BMED vs. PPH
Compare and contrast key facts about Future Health ETF (BMED) and VanEck Vectors Pharmaceutical ETF (PPH).
BMED and PPH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BMED is an actively managed fund by BlackRock. It was launched on Sep 29, 2020. PPH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Pharmaceutical 25 Index. It was launched on Dec 20, 2011.
Performance
BMED vs. PPH - Performance Comparison
Loading graphics...
BMED vs. PPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
BMED Future Health ETF | -4.26% | 21.79% | 1.55% | 5.70% | -19.69% | -3.96% | 17.86% |
PPH VanEck Vectors Pharmaceutical ETF | 2.25% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 8.63% |
Returns By Period
In the year-to-date period, BMED achieves a -4.26% return, which is significantly lower than PPH's 2.25% return.
BMED
- 1D
- 0.34%
- 1M
- -5.51%
- YTD
- -4.26%
- 6M
- 5.68%
- 1Y
- 22.21%
- 3Y*
- 7.39%
- 5Y*
- 0.40%
- 10Y*
- —
PPH
- 1D
- 1.55%
- 1M
- -4.34%
- YTD
- 2.25%
- 6M
- 12.24%
- 1Y
- 20.59%
- 3Y*
- 13.02%
- 5Y*
- 10.93%
- 10Y*
- 8.21%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BMED vs. PPH - Expense Ratio Comparison
BMED has a 0.85% expense ratio, which is higher than PPH's 0.36% expense ratio.
Return for Risk
BMED vs. PPH — Risk / Return Rank
BMED
PPH
BMED vs. PPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Future Health ETF (BMED) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BMED | PPH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.23 | 1.06 | +0.18 |
Sortino ratioReturn per unit of downside risk | 1.75 | 1.55 | +0.21 |
Omega ratioGain probability vs. loss probability | 1.24 | 1.20 | +0.04 |
Calmar ratioReturn relative to maximum drawdown | 1.60 | 1.81 | -0.20 |
Martin ratioReturn relative to average drawdown | 5.45 | 4.66 | +0.79 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BMED | PPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.23 | 1.06 | +0.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.02 | 0.74 | -0.72 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.49 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 0.31 | -0.18 |
Correlation
The correlation between BMED and PPH is 0.65, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
BMED vs. PPH - Dividend Comparison
BMED has not paid dividends to shareholders, while PPH's dividend yield for the trailing twelve months is around 2.06%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMED Future Health ETF | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PPH VanEck Vectors Pharmaceutical ETF | 2.06% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Drawdowns
BMED vs. PPH - Drawdown Comparison
The maximum BMED drawdown since its inception was -36.44%, smaller than the maximum PPH drawdown of -51.45%. Use the drawdown chart below to compare losses from any high point for BMED and PPH.
Loading graphics...
Drawdown Indicators
| BMED | PPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -36.44% | -51.45% | +15.01% |
Max Drawdown (1Y)Largest decline over 1 year | -12.31% | -10.02% | -2.29% |
Max Drawdown (5Y)Largest decline over 5 years | -33.90% | -20.26% | -13.64% |
Max Drawdown (10Y)Largest decline over 10 years | — | -29.70% | — |
Current DrawdownCurrent decline from peak | -10.30% | -5.56% | -4.74% |
Average DrawdownAverage peak-to-trough decline | -19.30% | -17.38% | -1.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.62% | 3.88% | -0.26% |
Volatility
BMED vs. PPH - Volatility Comparison
Future Health ETF (BMED) has a higher volatility of 5.98% compared to VanEck Vectors Pharmaceutical ETF (PPH) at 5.24%. This indicates that BMED's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BMED | PPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.98% | 5.24% | +0.74% |
Volatility (6M)Calculated over the trailing 6-month period | 10.87% | 12.00% | -1.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.24% | 19.72% | -1.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.42% | 14.87% | +2.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.81% | 16.95% | +0.86% |